[N+:1]([C:4]1[CH:5]=[C:6]([CH:17]=[CH:18][CH:19]=1)[NH:7][C:8]1[C:13]([C:14](=[O:16])[NH2:15])=[CH:12][CH:11]=[CH:10][N:9]=1)([O-:3])=[O:2].[H-].[Na+].[C:22](N1C=CN=C1)(N1C=CN=C1)=[O:23].O>O1CCCC1.CCOC(C)=O.CCOCC>[N+:1]([C:4]1[CH:5]=[C:6]([N:7]2[C:8]3[N:9]=[CH:10][CH:11]=[CH:12][C:13]=3[C:14](=[O:16])[NH:15][C:22]2=[O:23])[CH:17]=[CH:18][CH:19]=1)([O-:3])=[O:2]2-(3-Nitroanilino)-3-carbamoylpyridine (20 g, 77.5 mmole) was dissolved in tetrahydrofuran (2000 ml). Sodium hydride (60% dispersion in oil) (12.4 g, 310.0 mmole) was washed in hexanes and added to the solution. The solution was stirred for 5 minutes at room temperature under an inert atmosphere. To the solution, CDI (1,1'-carbonyldiimidazole) (18.8 g, 116.2 mmole) was added in a gradual manner over a period of 15 minutes, the resulting mixture was stirred at room temperature for 1 hour and subsequently refluxed for 24 hours. The solvent was removed resulting in a brown residue. Water was added to the residue and the resulting solution was extracted with ethyl acetate (5×300 ml). The phases were separated and the product was recrystallized from EtOAc/Et2O yielding a 12 g (42.4 mmole, 54.5% yield) of 1-N-(3-nitrophenyl)pyrido[2,3-d]pyrimidine-2,4(1H,3H)-dione (mp 262°-263° C.).